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SerotoninAlthough deep brain stimulation (DBS) showspromising efﬁcacy as a therapy for intractable depression, the neu-
robiological bases underlying its therapeutic action remain largely unknown. The present study was aimed at
characterizing the effects of infralimbic prefrontal cortex (IL-PFC) DBS on several pre-clinical markers of the
antidepressant-like response and at investigating putative non-neuronal mechanism underlying DBS action.
We found that DBS induced an antidepressant-like response that was prevented by IL-PFC neuronal lesion and
by adenosine A1 receptor antagonists including caffeine. Moreover, high frequency DBS induced a rapid increase
of hippocampal mitosis and reversed the effects of stress on hippocampal synaptic metaplasticity. In addition,
DBS increased spontaneous IL-PFC low-frequency oscillations and both raphe 5-HT ﬁring activity and synapto-
genesis. Unambiguously, a local glial lesion counteracted all these neurobiological effects of DBS. Further
in vivo electrophysiological results revealed that this astrocytic modulation of DBS involved adenosine A1 recep-
tors andK+buffering system. Finally, a glial lesionwithin the site of stimulation failed to counteract the beneﬁcial
effects of low frequency (30 Hz) DBS. It is proposed that an unaltered neuronal–glial system constitutes a major
prerequisite to optimize antidepressant DBS efﬁcacy. It is also suggested that decreasing frequency could height-
en antidepressant response of partial responders.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
With a lifetime prevalence of 16% in the United States, major
depressive disorder (MDD) is one of the most common psychiatric
disorders (Kessler et al., 2003). Despite the large range of availableﬁeld excitatory post-synaptic
imbic prefrontal cortex; L-AAA,
PCPA, 4-chloro-DL-phenylalanine
rveau, INSERMU846, Université
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. This is an open access article underpharmacological treatments, they remain unsatisfactory because of
their delayed onset of action (3–6 weeks) and their partial therapeutic
efﬁcacy. Indeed, 30–40% of patients are considered to have chronic
and refractory forms of MDD (Berton and Nestler, 2006). Recently,
high frequency deep brain stimulation (DBS) within the subcallosal cin-
gulate gyrus (SCG)was shown to rapidly improve depressive symptoms
in refractory patients, with 60% of patients being characterized as re-
sponders, including 35% of them in total remission (Mayberg et al.,
2005; Kennedy et al., 2011; Lozano et al., 2012). Despite these promis-
ing and exciting results, the neurobiological bases underlying DBS ther-
apeutic action remain largely unknown.
In rat, the anatomical connections and functional roles of the ventro-
medial prefrontal cortex (Gabbott et al., 2003) have led to consider
this region as the equivalent of the human SCG. The stimulation of the
ventromedial prefrontal cortex (vmPFC) induces antidepressant-likethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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reverses anhedonic-like behavior in animal models of depression
(Hamani et al., 2012). Curiously, they found that the antidepressant-
like behavioral response of DBS in the FST was unchanged after an
ibotenic acid-induced neuronal lesion of the vmPFC, suggesting the in-
volvement of “en-passant” ﬁbers (Hamani et al., 2010) and/or glial cells.
Glial cells are likely implicated in the physiopathology of depression.
Post-mortem studies have shown a decreased density of glial cells in the
prefrontal cortex and the hippocampus of depressed patients (Cotter
et al., 2001; Ongur et al., 1998). Accordingly, preclinical studies demon-
strated that a loss of astrocytes in the vmPFC induces depressive-like
behaviors (Banasr and Duman, 2008). More recently, it has been
shown that D-serine and ATP, two astrocytic transmitters, exert
antidepressant-like properties in rat and mice (Malkesman et al.,
2011; Cao et al., 2013), while glial-mediated modulation of glutamate
uptake in the PFC produces antidepressant-like effects by enhancing
cortical glutamate availability (Banasr et al., 2010). Considering that as-
trocytes are implicated in the processes of neurotransmission and syn-
aptic plasticity (Halassa and Haydon, 2010; Panatier et al., 2011), they
seem to be good candidates to interfere in DBS neurobiological action.
Importantly, recent in vitro data reported that DBS is associated with
an increase of ATP outﬂow within both thalamic and cortical slices,
resulting in an accumulation of adenosine, which in turn depresses ex-
citatory transmission through A1 receptor activation (Bekar et al., 2008).
The aims of the present study are to provide a better understanding
of the neurobiological bases of DBS, and to determine the role of glial
cells in the mechanism of action of DBS by using a gliotoxin speciﬁc
for astrocytes, the L-alpha-amino-adipic acid (L-AAA) (Brown and
Kretzschmar, 1998; Takada and Hattori, 1986). L-AAA infusion in vivo
induces a transitory ablation of astrocytes (Khurgel et al., 1996;
Takada and Hattori, 1986; Banasr and Duman, 2008; Lima et al., 2014)
by usingNa+-dependent transporter to enter into cells and block essen-
tial cellular functions involving glutamate, such as protein synthesis and
energetic metabolism (Brown and Kretzschmar, 1998). Thus, we have
studied, in sham and glial-lesioned rats, the in vivo effects of infralimbic
prefrontal cortex DBS (IL-DBS) on antidepressant-like behavior in the
FST, serotonin (5-HT) neuronal plasticity and function, dentate gyrus
mitogenesis, hippocampal synapticmetaplasticity and IL-PFC spontane-
ous low-frequency oscillations.
2. Materials and Methods
Materials and Methods section is detailed in Supplementary
Materials.
2.1. Animals
Efforts were made to minimize the number of animals used, as well
as their suffering. In this attempt, in vivo experimentswere not replicat-
ed for cell proliferation and electrophysiological experiments. However,
the same DBS treatment in control has been reproduced several times
throughout the manuscript thereby demonstrating the reproducibility
of our data. Sample size for each experiment was calculated using an
alpha of 0.05 and beta of 0.20. All animals were randomized for each
experiment and the experiments were blinded to the experimenter. Ex-
periments were carried out in male Sprague–Dawley OFA rats (Charles
Rivers, France) weighing from 260 to 320 g on the day of the experi-
ment. Experiments were performed in compliance with the European
Communities Council (86/609 ECC) for the care and use of laboratory
animals and ARRIVE guidelines and with the approval of the Regional
Animal Care Committees (University Lyon 1, CREEA Côte d'Azur).
2.2. Stimulation of the Prefrontal Cortex
To achieve IL-DBS, concentric bipolar stimulating electrodes (Rhodes
Medical Instruments, USA; SNEX-100, 0.25 mm diameter) werepositioned in the IL-PFC (in mm: 3.2 anterior and ±0.5 lateral to breg-
ma; between 5.2 and 5.5 ventral from the skull) in anesthetized rats.
Stimulation was conducted with an isolated pulse stimulator (model
2100, A-M Systems, USA) at 150 μA, 130 Hz and 60 μs (Hamani et al.,
2010).
2.3. Cortical Infusions
The L-alpha-aminoadipic acid (L-AAA) and the ibotenic acid were in-
fused bilaterally into the IL-PFC in anesthetized rats. All experiments
were carried out 48 h after the L-AAA infusion (20 μg/μL, ﬁnal dose of
100 μg/hemisphere) (Khurgel et al., 1996). The ibotenic acid (15 μg/μL)
was infused 7 days before FST.
The A1 receptor antagonist DPCPX, A1 receptor agonist CHA and
K+Cl− (2.7 or 30 mM) solutions were perfused within the IL-PFC
through a microdialysis probe.
2.4. Immunostaining
At the end of experiments, rats were transcardially perfused to eval-
uate the position of the glial lesion and quantify the number of GFAP-
positive cells in the IL-PFC using ﬂuorescent labeling of GFAP and
DAPI. Only animals showing lesions within the IL-PFC were included
in the study. For neuronal labeling, we used NeuN immunostaining.
To evaluate cell proliferation in the dentate gyrus of dorsal and
ventral hippocampi, rats were injected with BrdU (4 × 50 mg/kg i.p.)
every 2 h as previously described (Mnie-Filali et al., 2011).
2.5. Behavioral Experiments
Rats received continuous unilateral stimulation during 4 h after the
pre-test session of forced-swim test (FST) and 2 h before the test
session, 24 after (Fig. S3). The immobility duration was assessed by
image analysis through a specialized digital interface (Videotrack, View-
Point). Rats received (i.p.) 3 injections of either caffeine (2 mg/kg), the
selective antagonist of A1 receptors DPCPX (4 mg/kg) and the selective
antagonist of A2A receptors SCH4424164 (1 mg/kg).
The locomotor activity was performed using actimeter (Imetronic,
France).
2.6. Electrophysiological Recordings
2.6.1. 5-HT Cell Recordings
Extracellular unitary recordings of presumed DRN 5-HT neurons
were performed as previously described (Mnie-Filali et al., 2011). To de-
termine possible changes in the spontaneous ﬁring activity of presumed
5-HT neurons induced by 1 h IL-DBS, 3–4 successive descents were per-
formed along the DRN in each rat to ﬁnd about 6 neurons before and/or
6 neurons after the stimulation.
2.6.2. Field EPSP Recordings
The amplitude of ﬁeld excitatory post-synaptic potential (fEPSP)
was recorded in the CA1 stratum radiatumof hippocampus as previously
described (Mnie-Filali et al., 2006). LTD was induced by low frequency
stimulation (LFS), which consisted on biphasic square pulses (0.2 ms
duration) at 3 Hz during 5 min. After 30 min recordings, LTP was
induced by high frequency stimulation (HFS) which consisted on ten
trains at 0.5 Hz, each composed of 20 pulses at 200 Hz. DBS of the
IL-PFC was turned-on during the LFS and HFS of the hippocampus.
These recordings were also performed in stressed rats (using
elevated platform) and in 5-HT-depleted rats (using PCPA).
2.6.3. Local Field Potential Recordings
Abipolar electrode linkedwith a connectorwas chronically implanted
targeting the left IL-PFC. IL-DBS was applied during 4 h the second day
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latory activity within the IL-PFC was recorded during 5 min.
2.6.4. Statistical Analysis
All results are expressed as mean ± S.E.M. Comparisons between
groups were analyzed with analysis of variance. Statistical Analysis
section is detailed in Supplementary Materials and statistical analyses
for each ﬁgure are shown in Supplementary Table S1.
3. Results
3.1. Glial and Neuronal Modulations of the IL-DBS-Induced Antidepressant-
Like Response in the FST
Forced-swim test is a frequently used model to screen potential
antidepressants (Porsolt et al., 1977). In the present study, it was usedFig. 1.Modulation of the IL-PFC DBS-induced antidepressant-like response in the FST. (A) IL-DBS
time in the FST but prevented the antidepressant-like effect of IL-DBS. (B) Representative photom
treated rats. Black arrows represent the outline of the area where a complete disappearance of
glial lesion counteracted the decrease in immobility in FST induced by high frequency IL-DBS (
DBS (30 Hz) (**p b 0.01 and ***p b 0.001 vs sham, ##p b 0.01 vs IL-DBS). (D) Schematic repre
(130 Hz) (black squares) or L-AAA + DBS- (130 Hz) (gray dots) treated animals for the Fig. 1C
in FST. SCH442416 induced a reduction of immobility on its own in the FST, but failed to prevent
induced by IL-DBS in FST (**p b 0.01 and ***p b 0.001 vs vehicle and #p b 0.05). Results are ex
represent the number of rats tested per group.to highlight antidepressant-like behavior induced by IL-DBS and its
putative glial modulation in rats infusedwith vehicle or L-AAA gliotoxin
in the IL-PFC. As illustrated in Fig. 1D, stimulation electrodes were
implanted unilaterally in the infralimbic part of the vmPFC. Two
sessions of IL-DBS (Fig. S3) signiﬁcantly decreased immobility duration
in rats with intact IL-PFC demonstrating an antidepressant-like effect of
DBS (Fig. 1A). To determinewhether IL-DBS involved the local neuronal
population, its antidepressant-like effect was assessed in rats infused
with ibotenic acid 7 days before the FST (Fig. 1A and B). Our results
revealed that neuronal lesion had no effect by itself in the FST, as previ-
ously shown (Banasr and Duman, 2008), but robustly prevented the
antidepressant-like effect of IL-DBS. Interestingly, the antidepressant-
like effect of DBS was prevented by a loss of astrocytes within the stim-
ulated area after L-AAA infusion in rat's IL-PFC (Fig. 1C). Glial lesion had
no effect by itself on immobility duration and did not alter locomotor
activity of rats (Fig. S4).induced a decrease in immobility in FST. Ibotenic acid infusion had no effect on immobility
icrograph of a coronal NeuN-immunostained section containing the IL-PFC from ibotenic-
NeuN-immunoreactivity was observed after an ibotenic acid infusion in IL-PFC. (C) IL-PFC
130 Hz) but did not prevented the antidepressant-like effect induced by low frequency IL-
sentation of coronal brain sections showing the location of implanted electrodes in DBS-
(left) groups. (E) Caffeine (Caf.) abolished the decrease of immobility induced by IL-DBS
the IL-DBS-induced antidepressant-like effect. DPCPX abolished the decrease of immobility
pressed as mean ± SEM of immobility duration. Numbers at the bottom of the columns
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experiments after a functional disruption of the astrocytic syncytium
using the non-speciﬁc blocker of astroglial gap junction carbenoxolone
(Juszczak and Swiergiel, 2009; Sun et al., 2012). Importantly, we
found that gap junction blockade at the site of stimulation also
prevented the antidepressant effect of IL-DBS (Fig. S5). Similarly, to fur-
ther probe a role of glia cells on the effects of IL-DBS in the FST, we rep-
licated these experiments under lower frequency IL-DBS, i.e., 30 Hz. Our
results showed that IL-DBS at 30 Hz signiﬁcantly decreased immobility
duration in sham rats revealing an antidepressant-like effect. Impor-
tantly, the latter effect of IL-DBS at 30 Hz was not modiﬁed by a glial le-
sion (Fig. 1C). Noteworthy, neither glial lesion nor electrode
implantation affected by themselves time immobility in the FST, such
results contrasted with previous studies (Banasr and Duman, 2008;
Lee et al., 2013; Perez-Caballero et al., 2013) mainly because of the use
of a different technical procedure (see Figs. S6 and S8).
3.2. Effects of Adenosine A1/A2A Receptor Antagonists on IL-DBS
Antidepressant-Like Response in the FST
Kaster et al. (2004, 2012) have previously shown that adenosine A1
agonists (injected i.c.v. and i.p.) induce antidepressant-like effects in the
FST. Considering that DBS is associated to the accumulation of adeno-
sine (Bekar et al., 2008), we investigated the involvement of adenosine
transmission in DBS-induced behavioral effects. Systemic injections of
caffeine, which is a non-selective antagonist of adenosine receptors,
prevented the decrease of immobility in the FST induced by IL-DBS
(Fig. 1E) without affecting spontaneous locomotor activity of rats
(Fig. S4). To further characterize this effect, the A2A receptor antagonist
SCH442416 and the A1 receptor antagonist DPCPX were then adminis-
tered in control and stimulated rats (Fig. S3). Although the immobility
time was signiﬁcantly decreased in SCH442416-injected rats comparedFig. 2. Effects of a local glial lesion on IL-DBS-induced enhancement of dentate gyrus mitogenes
in top ×10 and bottom ×40, enlarged view of boxed area in top) of sham and DBS-treated ra
mitogenesis in dorsal and ventral hippocampi (*p b 0.05, **p b 0.01 vs sham), an effect counte
bottom of the columns represent the number of rats per group.to sham, the antidepressant-like effect of IL-DBS was still signiﬁcantly
present in rat pre-treated with SCH442416 (Fig. 1E). Given that
SCH442416 signiﬁcantly decreased locomotion (Fig. S4), SCH442416 in-
duced an antidepressant-like response that was not attributable to an
increase in locomotor activity. On the other hand, the administration
of the A1 receptor antagonist DPCPX signiﬁcantly prevented the
antidepressant-like effect of DBSwithout altering spontaneous locomo-
tion (Fig. S4).
3.3. Glial Modulation of IL-DBS-Induced Enhancement of Hippocampal
Mitogenesis
The neurogenic hypothesis of depression postulates that decreased
production of new granule cells in the DG is linked to the pathophysiol-
ogy of depression and that increased hippocampal neurogenesis is re-
quired for the behavioral effects of antidepressant treatment (Malberg
et al., 2000; Santarelli et al., 2003). In the present study, the effect of
2 h IL-DBS (130 Hz, 150 μA bilaterally) on dorsal and ventral hippocam-
pal mitogenesis was evaluated after BrdU labeling (Fig. 2A, Fig. S3). Re-
markably, IL-DBS signiﬁcantly increased mitogenesis in the dentate
gyrus of dorsal and ventral hippocampi, an effect that was signiﬁcantly
prevented by a glial lesion within the stimulated area (Fig. 2B). Note-
worthy, the glial lesion had no effect by itself onmitogenesis in the hip-
pocampus, a result that correlated well with the lack of depression-like
effect of the L-AAA infusion.
3.4. Glial Modulation of IL-DBS-Induced Changes on Synaptic
Metaplasticity in Dorsal Hippocampus
Hippocampal synaptic plasticity is considered as a reliable preclini-
cal parameter allowing the characterization of antidepressant-induced
changes in the molecular and physiological events that underpin theis. (A) Representative photomicrographs of dorsal and ventral hippocampi (magniﬁcation:
ts. BrdU-positive cells (black) were seen in granule cell layer (GCL). (B) IL-DBS increased
racted by L-AAA infusion (#p b 0.05, ###p b 0.001 vs DBS-treated rats). Numbers at the
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(Berton and Nestler, 2006; Pittenger and Duman, 2008). Hence, the
modulation of hippocampus synaptic metaplasticity by IL-DBS and
glial lesion was examined in vivo by application of low and high fre-
quency stimulations (LFS and HFS) on Schaffer's collateral pathway to
induce long-term depression (LTD) or long-term potentiation (LTP),
respectively, in hippocampal CA1 area (Fig. 3A inset).
As expected in dorsal hippocampus of naïve rats, LFS failed to induce
a LTD and HFS resulted in a LTP of approximately 30% (Fig. 3A and C).
Interestingly, while concomitant IL-DBS did not modify ﬁeld excitatory
post-synaptic potential (fEPSP) after LFS, it blocked the LTP induction
after HFS, a result that is consistent with previous data showing a de-
crease of LTP after acute antidepressant administrations (Shakesby
et al., 2002; Mnie-Filali et al., 2006). Notably, L-AAA infusion within
the IL-PFC signiﬁcantly reduced the LTP after HFS compared to sham
and prevented IL-DBS-induced blockade of LTP after HFS (Fig. 3A and
C). Statistical analysis detected a signiﬁcant interaction between the
effects of IL-DBS and L-AAA infusion demonstrating that the effect of
IL-DBS on synaptic plasticity is dependent of an intact glial system.
To further characterize the modulation of hippocampus synaptic
metaplasticity by IL-DBS and glial lesion, we replicated these experi-
ments in stressed rats (Fig. 3B). An acute stress was induced by placing
animals on a circular elevated platform for 30 min before electrophysi-
ological recordings. As expected in the dorsal hippocampus of stressed
rats (Xu et al., 1997), LFS induced a stable LTD of approximately 17%
whereas HFS failed to elicit a LTP (Fig. 3B and C). Interestingly, concom-
itant IL-DBS reversed the effects of stress on both LTD and LTP. Impor-
tantly in L-AAA-infused rats, IL-DBS failed to counteract the LTD and
LTP-blockade induced by stress (Fig. 3B and C).
To characterize the involvement of the 5-HT system in the modula-
tion of hippocampal metaplasticity by IL-DBS, a serotoninergic deple-
tion was performed using the 5-HT synthesis inhibitor PCPA. PCPAFig. 3. Effects of a glial lesion on IL-DBS-induced changes in hippocampal synaptic metaplasticit
and a recording electrode in the hippocampus and a DBS electrode in the IL-PFC. Time-course r
responses in stressed rats illustrating the effects of glial lesion on DBS modulation of synaptic p
stimulations; calibration vertical bar, 0.5 mV; horizontal bar, 5 ms. (C) Area Under the Curve (A
sham and stressed rats. (D) AUC histograms illustrate changes induced after LFS orHFS by IL-DB
number of rats per group (*p b 0.05 **p b 0.01 and ***p b 0.001 vs naïve sham. #p b 0.05, ##p bpre-treatment induced LTD after LFS and prevented LTP induction
after HFS on its own. Importantly, DBS failed to further decrease
AUC in PCPA-treated rats suggesting that serotoninergic depletion
totally prevented the decrease of LTP induced by IL-DBS (Fig. 3D).
Statistical analysis revealed a signiﬁcant interaction between the
effects of IL-DBS and serotonin depletion after HFS, suggesting
that IL-DBS-induced effects on synaptic plasticity are modulated by
serotonin.
3.5. Glial Modulation of IL-DBS-Induced Enhancement of Slow Oscillatory
Activity Recorded in the IL-PFC
Disrupted low oscillatory activity has been reported in animalmodel
of depression (Voget et al., 2015; Gazit et al., 2015). As illustrated in
Fig. 4, analysis of spontaneous local ﬁeld potentials and relative power
spectra revealed that IL-DBS increased low frequency bands (0–21 Hz)
within the IL PFC compared to sham rats (Fig. 4A and B). Analysis of
the percentage of total power spectrum (Fig. 4C) showed that IL-DBS
signiﬁcantly enhanced the δ, θ, α, and β frequencies in comparison to
non-stimulated animals. Importantly, the latter effect was signiﬁcantly
abolished in L-AAA infused animals while a glial lesion had no effect
by itself on slow waves activities recorded in the IL-PFC.
3.6. Glial Modulation of IL-DBS-Induced Enhancement of the Spontaneous
Activity of Presumed DRN 5-HT Neurons
Classical antidepressants are well known to enhance serotoninergic
neurotransmission, with a time course that is consistent with the onset
of their therapeutic effects (Blier and deMontigny, 1994). In the present
study, the ﬁring activity of presumed 5-HT neurons was recorded in the
dorsal raphe nucleus (DRN) before and/or after 1 h of stimulation of the
IL-PFC (30 and 130 Hz, 150 μA bilaterally) in anesthetized rats (Fig. S3).y. (A) Inset: schematic representation of the experimental protocol showing a stimulating
esponses illustrate changes induced by DBS and glial lesions in naïve rats. (B) Time-course
lasticity. Insets show typical ﬁeld EPSPs recorded before and after low and high frequency
UC) histograms illustrate changes induced after LFS or HFS by IL-DBS and/or glial lesion in
S and/or PCPA injections in naive rats. Numbers at the bottomof the columns represent the
0.01 and ###p b 0.01 vs DBS-treated group, αp b 0.05 vs stress group).
Fig. 4. Effects of a glial lesion on IL-DBS-induced enhancement of slow oscillatory activity. Spontaneous local ﬁeld potentials and relative power spectra of low frequency bands (0–21 Hz)
within the IL PFC in sham (A) and IL-DBS-treated rats (B). (C) Percentage of total power spectrum showed that IL-DBS signiﬁcantly enhanced the δ, θ, α, and β frequencies, an effect
abolished by glial lesion (***p b 0.001 vs sham, n = 4–5 rats per group).
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DBS, 1 h of IL-DBS signiﬁcantly increased the spontaneous activity of
presumed 5-HT neurons by 34% in physiological conditions ([K+] =
2.7 mM, Fig. 5A and B). This effect was current-dependent since 1 h
stimulation at 20 μA and 130Hz had no effect on presumed 5-HT neuro-
nal spontaneous ﬁring [1.1 ± 0.02 Hz before DBS (n = 37) vs 1.2 ±
0.02 Hz post-DBS (n = 32), p N 0.05 Student's t-test].
In L-AAA-treated rats the ﬁring activity of presumed 5-HT neurons
was surprisingly enhanced (Fig. 5B). However, analysis ofﬁringpatterns
revealed that the latter ﬁring rate increase was associated with the en-
hancement of burst ﬁring activity of 5-HT neurons [percent of spike in
burst in sham rats: 14.2 ± 2.6%, n = 100; after 1 h DBS: 11 ± 2.9%,
n = 71; in L-AAA rats: 27.7 ± 0.59%, n = 59; after 1 h DBS: 32.6 ±
0.81%, n= 48; p b 0.001, Table S1]. In the sameway, IL-PFC inactivation
with carbenoxolone identically induced an increase of 5-HT ﬁring rate
[0.97 ± 0.06 Hz in sham rats (n = 100); 1.35 ± 0.13 Hz in cbx-
treated rats (n = 41), p = 0.02 Student's t-test] and an aberrant in-
crease of phasic activity of 5-HT neurons [percent of spike in burst in
sham rats: 14.2 ± 2.6%; in cbx rats: 32.4 ± 11.2%; p = 0.027,
Table S1] without altering emotional behavior in the FST (Fig. S4).
To mimic the enhancement of extracellular K+ concentration
induced by glial lesion, we perfused high concentration of KCl in the
aCSF with a microdialysis probe implanted in the IL-PFC and we
assessed the effect of IL-DBS on 5-HT neuronal ﬁring activity (infusion
of KCl performedduringDBS and recordings). Similarly to L-AAA glial le-
sion, in presence of elevated [K+] (30 mM), the spontaneous ﬁring rateof presumed 5-HTneuronswas signiﬁcantly enhanced and, remarkably,
the facilitating effect of high frequency IL-DBS on 5-HT ﬁring activity
was also prevented (Fig. 5B). Importantly, the enhancing effect of
DBS-30 Hz on 5-HT neuronal ﬁring was not altered by the glial lesion
[1.57 ± 0.10 Hz in L-AAA-treated rats (n = 42); 2.03 ± 0.14 Hz in
IL-DBS + L-AAA-treated rats (n = 39), p = 0.01].
Since we demonstrated that adenosine A1 receptors were involved
in the antidepressant effect of IL-DBS in the FST, we have explored the
effects of the selective A1 receptor antagonist DPCPX infused via a mi-
crodialysis probe within the IL-PFC. High concentration of DPCPX
(100 μM) infused during recordings (without IL-DBS) increased by itself
5-HTﬁring rate in shamanimals [0.97±0.12Hz before DPCPX (n=37)
vs 1.4 ± 0.13 Hz post-DPCPX (n = 33), p b 0.05 Student's t-test]. As
demonstrated above, 1 h of high frequency IL-DBS signiﬁcantly
increased by 40% the ﬁring activity of presumed 5-HT neurons, as
well as 1 h of low frequency IL-DBS (30 Hz, Fig. 5C). Remarkably, high
concentration of DPCPX (100 μM), infused during the stimulation, sig-
niﬁcantly prevented the high frequency (130 Hz) DBS-induced en-
hancement of ﬁring activity of presumed-5-HT neurons (Fig. 5C) but
failed to prevent the enhancing effect of lower frequency IL-DBS
(30 Hz) on the spontaneous activity of presumed 5-HT neurons
(Fig. 5C). In the same way, the non-selective adenosine receptor antag-
onist caffeine (2 mg/kg, i.p.) increased by itself 5-HT ﬁring rate [0.98 ±
0.13 Hz before caffeine (n = 37) vs 1.90 ± 0.19 Hz post-caffeine (n =
27), p b 0.001]. Nevertheless, there was no additive effect between IL-
DBS-induced ﬁring enhancement and caffeine-induced increased 5-HT
Fig. 5. Effects of IL-DBS on 5-HT neuronal ﬁring. (A) Integrated ﬁring rate histograms of 5-HT neurons recorded in one descent before and one descent after IL-DBS. Number above histo-
grams: μmdepth of the recorded neurons from sylvius aqueduct. (B) High frequency IL-DBS enhanced 5-HT neuronal ﬁring in condition of normal K+ concentration (2.7mM). Glial lesion
performedwith L-AAA or K+ high concentration (30mM) infusion increased 5-HT neuronal activity and counteracted the effect of IL-DBS. *p b 0.05 and ***p b 0.001 vs basal activity of K+
2.7mM infused group; ns=non-signiﬁcant (C) IL-DBS (130 and 30Hz) increased 5-HT neuronalﬁring, an effect prevented byDPCPX for high frequency IL-DBS. *p b 0.05 and **p b 0.01 vs
basal activity; #p b 0.05 (D) Infusion of CHA reversed the effect of the glial lesion (###p b 0.001 CHA vs vehicle in L-AAA-treated rats), an effect counteracted by the A1 receptor antagonist
DPCPX. Numbers in the columns represent the number of 5-HT cells recorded per group (*p b 0.05 vs sham).
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DBS + caffeine (n = 27), p N 0.05].
We then hypothesized that the enhancement of the ﬁring rate of
5-HT neurons observed in L-AAA infused rats was due to the absence
of an inhibitory tone on glutamatergic neurons of IL-PFC exerted by as-
trocytes through adenosine A1 receptors. To test this hypothesis, the
adenosine A1 receptor agonist CHA (10 μM) and antagonist DPCPX
(10 μM) were locally administered in IL-PFC via a microdialysis probe
during DRN 5-HT neurons recording. In control rats, neither CHA nor
DPCPX (at low dose of 10 μM) altered 5-HT ﬁring rate in sham animals
(Fig. 4D, left). Interestingly in L-AAA-treated rats (Fig. 4D, right), CHA
decreased the L-AAA-induced enhancement of ﬁring rate of 5-HT neu-
rons. Moreover, co-administration of DPCPX prevented this effect.
These results indicate that IL-PFC A1 receptors exhibited increased sen-
sitivity to CHA in L-AAA infused rats. Note that if the adenosine A1 ago-
nist CHA (10 μM) did not alter by itself 5-HT ﬁring rate in sham animals
(Fig. 4D left), CHA enhanced the action of IL-DBS at 130 Hzwhen it was
infused during the stimulation [1.358 ± 0.11 Hz post-DBS (n = 34) vs
1.92 ± 0.15 Hz post-DBS + CHA (n = 27), p = 0.003 Student's t-test].
The obtained results clearly indicate for the ﬁrst time that IL-PFC A1
receptor is an important and labile modulator of the DBS action in
controlling DR 5-HT neurons.
We then sought to assess the molecular bases underlying the DBS-
induced enhancement of 5-HT neurons ﬁring activity, by addressing
the possibility that rapid synaptic growth and/or modiﬁcations may ac-
count for the observed effects. Indeed, in our experimental conditions,the increased 5-HT ﬁring rate was observed up to 1 h after the end of
DBS. It is very unlikely that such a long-lasting action could be related
to increased levels of an excitatory transmitter (i.e., glutamate) at the
vicinity of 5-HT cell bodies because synaptic washout occurswithin sec-
onds. However, a synaptic reinforcement at the level of the dorsal raphe
might be involved in the excitatory effect described above. To test this
hypothesis, PSD-95 and synapsin mRNA expression were quantiﬁed
by using quantitative RT-PCR on micro-dissected samples of raphe.
These two proteins are known as markers of neuronal post- and pre-
synaptic plasticity, respectively (Sheng and Kim, 2002). One hour of
DBS was associated with enhanced relative expression levels of both
PSD-95 and synapsinmRNA in the DRN (Fig. S7). Interestingly, these ef-
fects were suppressed after IL-PFC infusion of L-AAA. This increase in
mRNA level is associated with an enhanced protein level expression
only for PSD-95. A non-signiﬁcant decrease in synapsin protein level
expression was observed. Together, these results suggested that post-
synaptic neuronal markers were up-regulated within the DRN in re-
sponse to acute DBS.
3.7. L-AAA Infusion Reduced the Number of GFAP-Positive Cells
In agreement with recent data (Lima et al., 2014), our study reports
that L-AAA infused within the IL-PFC induced, 48 h later, a robust loss of
GFAP-positive cells close to the infusion area (Fig. S1A and B). Compar-
ison between vehicle- and L-AAA-infused rats showed a signiﬁcant de-
crease of 70% of the number of GFAP-positive cells/mm2 conﬁned to
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Fig. S1B) since astrocyte numbers were not affected in front of and be-
hind the gliotoxin infusion area. Notably, NeuN immunostaining within
IL-PFC clearly demonstrated no difference in the number of NeuN-
positive cells in L-AAA-infused rats compared to sham (Fig. S2), indicat-
ing that L-AAA did not induce neuronal loss within the IL-PFC 48 h after
local infusion.
4. Discussion
Astrocytes seem to be good candidates to interfere in theDBS neuro-
biological action (Vedam-Mai et al., 2012) since they are implicated in
the processes of neurotransmission and synaptic plasticity (Panatier
et al., 2011; Halassa and Haydon, 2010). Accordingly, Bekar et al.
(2008) have shown in vitro that DBS is associated with an increase
of ATP outﬂow within the thalamus, resulting in an accumulation
of adenosine, which, in turn, depresses excitatory transmission
through A1 receptor activation. Astrocytes are indeed able to release
gliotransmitters, among which ATP which is mainly considered as an
excitatory transmitter. However, ATP is also rapidly hydrolyzed into
adenosine, which has been reported to act as a powerful inhibitor of ex-
citatory transmission/neuronal communication through the stimulation
of adenosineA1 receptors (Pascual et al., 2005). Interestingly, our in vivo
electrophysiological results demonstrate that the administration of the
A1 receptor antagonist DPCPX or caffeine enhanced by itself 5-HT neu-
ronal ﬁring. It is likely that such an A1-dependent control of 5-HT neu-
rons is mediated, at least in part, by a modulation of the glutamatergic
descending projections from the IL-PFC. Indeed, both electric (Celada
et al., 2001) and optogenetic (Warden et al., 2012) stimulations of
these projections have revealed that they primarily exert a stimulatory
effect on 5-HT cell bodies. In addition, a very recent study using both
electrophysiological and optogenetical techniques, demonstrates a
“hyperdirect” excitatory PFC pathway providing a direct excitatory con-
trol of 5-HT neurons, most likely important for proper activity of the 5-
HT system (Pollak Dorocic et al., 2014). Our results suggest therefore in-
directly the existence of an A1 mediated inhibitory tone on PFC pyrami-
dal cells.Moreover, both a glial loss (with L-AAA) and a glial inactivation
(with cbx) in the IL-PFC also induced an increase of presumed 5-HT
neuronal activity, an effect that appears to be related to an “aberrant”
enhancement of the bursting activity of 5-HT neurons. It is possible
that such a paradoxical increase is, at least in part, consequent to a dis-
inhibition, related to the suppression of this A1-dependent tonus as re-
vealed by the presence of the sensitization of A1 receptors.
To date, the recently proposed hypothesis deciphering the mode of
action of DBS points toward a functional inactivation of neuronal activ-
ity in the stimulated area, and an excitation of direct axonal and ﬁber
pathways near the electrodes that would regulate distant structures
(Montgomery and Gale, 2008; Vitek, 2002). In support to this hypothe-
sis, our study demonstrated that high frequency stimulation of the
IL-PFC produced a current-dependent increase of the presumed DRN
5-HT neuronal ﬁring rate, suggesting an increased glutamatergic output
from IL-PFC projections (Peyron et al., 1998; Celada et al., 2001). In
agreement with a recent study (Veerakumar et al., 2014), our results
showed that acute IL-DBS increased synaptogenesis within the DRN,
an effect that should favor the glutamatergic tone exerted by IL-PFC ter-
minals on serotoninergic neurons. Indeed, increasedmRNA for the post-
synaptic marker PSD-95 and the presynaptic protein synapsin were
observed in the DRN of stimulated rats. In the same way, increased
PSD-95 protein level indicate that this marker of postsynaptic density
is increased within the DRN, suggesting that processes of synaptic
growth have been triggered by vmPFC DBS. Besides, the fact that
mRNA and protein levels of synapsin appear to be modulated in an op-
posite way by the stimulation suggest that the synthesis of this factor
has increased within DRN cells, but that the protein itself has started
to migrate outside the observed brain structure. This is in agreement
with the presynaptic nature of synapsin as a promoter of vesicularformation, and would indicate that 5-HT neurons are more activated
andmoremobilized to release their transmitter after DBS. This explana-
tion is fully compatible with the fact that both behavioral (i.e., in the
forced swim test) and electrophysiological (i.e., on 5-HT neurons) ef-
fects of IL-DBS were still present after the stimulator had been turned
off. This enhancement of 5-HT neurotransmission might be implicated
in DBS-induced effects on dorsal and ventral hippocampi. Indeed, we
demonstrated that the capacity of IL-DBS to block LTP induction de-
pends on the integrity of the 5-HT system since 5-HT depletion pro-
duced by PCPA abolished this effect. Accordingly, it was shown that 5-
HT is able to potentiate synaptic transmission through the activation
5-HT4 receptors (Kobayashi et al., 2008) which are known to play a
key role in the regulation of synaptic plasticity in CA1 (Kemp and
Manahan-Vaughan, 2004, 2005) and to inﬂuence learning andmemory
(Lamirault and Simon, 2001; Moser et al., 2002). In the sameway, it has
been reported that the effects of DBS in the FST are completely abolished
in 5-HT lesioned rats (Hamani et al., 2012). Hence, these results strongly
suggested that the effects of IL-DBS on synaptic plasticity and
mitogenesis are mostly mediated by 5-HT and that the integrity of 5-
HT system is crucial for the antidepressant efﬁcacy of DBS.
The present study reveals that an ibotenic acid lesion within the IL-
PFC prevented the antidepressant-like effect of DBS, showing that
local neuronal population is implicated in the effects of the stimulation,
and is not just “inactivated” as currently hypothesized. When activated
by DBS, pyramidal neurons and their axons would release an augment-
ed quantity of glutamate, leading to an over-activity of presumed 5-HT
neurons within the DRN and an increase of 5-HT release in terminal
areas (Fig. 6). Taken together, these results support the view that the
antidepressant-like effect of a cortical stimulation might be mediated
by both the activation of local neuronal population and the excitation
of axons and passing ﬁbers that would enhance, among others, 5-HT
neurotransmission (Amore detailed discussion on this “excitation vs in-
hibition theory” is provided in the SupplementaryMaterial). According-
ly, we demonstrated that the antidepressant-like effect of IL-DBS was
associatedwith an increase of slowoscillatory activitieswithin the stim-
ulated area, an effect prevented by local L-AAA infusion. A similar in-
crease has been observed following ECT therapy, associated with an
augmentation of IL-PFC synaptogenesis and gliogenesis (Bouckaert
et al., 2014). Together, these ﬁndings raise the interesting hypothesis
that fast-acting AD strategies share the common feature of re-
enforcing intra-IL-PFC connections, which in turn may strengthen the
positive modulation exerted by pyramidal neurons on their subcortical
targets like theDRN. If so, the involvement of astrocytes in theADeffects
of DBS, would not be surprising given their importance in the processes
of synaptic plasticity and reinforcement.
Another most prominent and studied role of astrocytes is their abil-
ity tomaintain the potassiumhomeostasis, by actively pumpingK+ ions
from the extracellular level, thus preventing them to accumulate due to
neuronal activity (Kofuji and Newman, 2004; Noori, 2011; Larsen and
MacAulay, 2014). Accordingly, the glial K(ir)4.1 channel is crucial for
the maintenance of the resting membrane potential of glial cells and
play a main role in the homeostasis of extracellular potassium as previ-
ously also shown in vivo in glial-conditional knock-out K(ir)4.1 mice
(Chever et al., 2010). For this reason, we also hypothesized that an in-
creased extracellular concentration of K+ mimicked the effect of a
glial lesion. Hence, we used reverse microdialysis to perfuse the IL-PFC
with a K+-enriched aCSF (Fig. 5B). The obtained results conﬁrmed our
working hypothesis, as 5-HT neuronal ﬁring rate in high intra-mPFC
[K+] condition was very similar to that of L-AAA lesioned rats, both in
basal situation and after DBS. One may assume that an alteration of as-
trocyte functionwithin the lesioned sitewould lead to an increase of ex-
tracellular [K+], which in turnwould produce a depolarization of IL-PFC
neuron membrane. In the absence of any stimulation, these effects are
expected to facilitate pyramidal neuron activity within the mPFC, and
consequently in its projection areas such as the dorsal raphe. This is pre-
cisely what is observed in non-stimulated animals. However, the
Fig. 6. A. Schematic representation of our working hypothesis on themechanisms of action of IL-DBS. IL-DBS would activate glutamatergic neurons and increase glutamate concentration
within the dorsal raphe. Thiswould enhance theﬁring rate 5-HT neurons. Consequently, 5-HT release is enhanced in the hippocampus, inﬂuencing neurogenesis and synaptic plasticity. B.
Astrocytes, by releasing gliotransmitters (such as glutamate and ATP), communicatewith neurons at the synapse. Glutamate stimulates neuronal synaptic release andwould contribute to
the activation of post-synaptic receptors. ATP is rapidly hydrolyzed into adenosine (adeno),whichwould increase the stimulation of adenosineA1 receptors and, in turn, should result on a
K+ channel-mediated reduction of the late hyperpolarization phase of action potentials (Sasaki et al., 2011). Ultimately, the resulting temporal shrinking of action potentials (AP width, in
orange) may help the neuron to sustain the high frequency demand related to IL-DBS. Astrocytes also maintain the potassium homeostasis, by actively pumping K+ ions from the extra-
cellular level thus preventing them to accumulate due to neuronal activity (in blue). A loss of astrocytes should therefore lead to an increase of extracellular [K+], which in turn would
produce a depolarization of IL-PFC neuron membrane. This would facilitate basal pyramidal neuron activity, but, due to a “ceiling” phenomenon, would also likely impair the ability of
pyramidal cells to respond to the phasic, high-frequency solicitation related to DBS. Actually, an increase of extracellular [K+] mimicked a glial lesion effect.
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pair the ability of pyramidal cells to respond to the phasic, high frequen-
cy solicitation demanded to sustain the stimulation at 130Hz. Again, the
obtained results, showing that 130 Hz DBS is unable to further affect 5-
HT activity in the presence of 30 mM of K+, are in support of this latter
hypothesis.
Also, it appears paradoxical to note that adenosine, via A1 receptors,
can inhibit cell ﬁring under basal condition (as revealed by the disinhi-
bition with DPCPX and caffeine) and can also participate in sustaining
ﬁring under high frequency of stimulation (as revealed with the poten-
tiating action of CHA). Interestingly, a study aiming at dissecting the role
played by A1 receptors in the shape of action potentials and in the reg-
ulation of axonal conductance reveals in vitro that the administration
of DPCPX increases the width of axonal action potentials, suggesting
that astrocytes, through the release of adenosine and subsequent A1 re-
ceptor stimulation,might be able tomodulate the shape of axonal action
potentials (Sasaki et al., 2011). The authors show that this latter effect is
due to themodulation of the voltage-activated K+ channels responsible
for neuronal after hyperpolarization. As suggested, a temporal shrinking
of action potentials can be beneﬁcial when the neuron is solicited in re-
sponse to high-frequency stimulations, permitting to sustain a bursting
activity that requires very short inter-spike intervals. However, when
the neuron ﬁres at a low frequency, the increased late-phase hyperpo-
larizing K+-current induced by A1 stimulation (Sasaki et al., 2011)
should have only marginal inhibitory effects, which would account for
the results in basal conditions. In accordance with these latterhypotheses and results, we demonstrated that the effects of astroglial
lesion on IL-DBS-induced effects are frequency-dependent. Under anes-
thesia, the resting frequency of mPFC pyramidal neurons is around 2 Hz
(Llado-Pelfort et al., 2012), and imposing a frequency of 30 Hz already
constitutes a potent paradigm to solicit their excitation. In the absence
of astrocytes, the depolarization of neuron membrane related to K+ ac-
cumulation did not reach a supra-threshold, “depolarization block-like”
level, and that pyramidal neurons were still able to follow a moderate
DBS at 30 Hz contrary to DBS at 130 Hz. Taken together, putative mecha-
nisms involved in the inﬂuence of a glial lesion on IL-PFC and DRN 5-HT
functions can be suggested. They are both based on the multiple controls
that K+-mediated transmembrane currents are able to exert on neuronal
excitability (“ceiling depolarization” hypothesis) and response (“shrink-
ing” hypothesis). Although other mechanisms of action, either ionic or
non-ionic, may underlie the function of IL-PFC astrocytes in DBS condi-
tions, it remains that these two hypotheses are in good agreement with
the results observed in our in vivo experimental conditions. It is likely
that the regulation of extracellular K+ within the mPFC plays actually a
key role in this context (Fig. 6). At any rate, our results also highlight
the important role played by glia in the stress buffering effects of the be-
havioral controlmediated by coordinated activity of themPFC–DRNpath-
way (Maier andWatkins, 2010; Warden et al., 2012).
In conclusion, the present study shows that a glial lesion within the
site of stimulation counteracted the beneﬁcial effects of IL-DBS at 130
but not 30 Hz. As translational outcome, it is proposed that an unaltered
neuronal/glial system constitutes a major prerequisite to optimize
907A. Etiévant et al. / EBioMedicine 2 (2015) 898–908antidepressant DBS efﬁcacy. It is also suggested that decreasing fre-
quency (e.g., to 30 Hz) could heighten antidepressant response of par-
tial responders and that consuming caffeine might be at risk of
weakening the beneﬁcial action of DBS.
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